Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Rosenholm Pharma & Management Consulting AB
AB
Active
Org 5594190885
Musselvägen 21, 181 66
Lidingö
Business and other management consultancy activities
· NACE 7020
Est. 2023
0 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Rosenholm Pharma & Management Consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
1M
2023
2M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
1M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
631
1 666
Staff expenses
−157
−929
EBITDA
411
626
Depreciation & amort.
—
—
EBIT
411
626
Net financials
0
2
Profit before tax
411
628
Tax
−87
−131
Net profit
324
496
Balance sheet
SEK thousands
Item
2023
2024
Total assets
549
1 217
Equity
349
845
Long-term debt
—
—
Short-term debt
200
371
Total debt
200
371
Financial ratios
5-year trend
EBITDA margin
37.6%
This company
15.8%
Market median
+138% vs market
2023
2024
Equity ratio
69.5%
This company
38.2%
Market median
+82% vs market
2023
2024
Return on equity
58.7%
This company
18.4%
Market median
+219% vs market
2023
2024
Net profit margin
29.8%
This company
8.1%
Market median
+268% vs market
2023
2024
Asset turnover
1.37×
This company
1.12×
Market median
+22% vs market
2023
2024
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-23 – 2023-12-31
View
PDF
More on Rosenholm Pharma & Management Consulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
